NCT02602496

Brief Summary

This study evaluates the impact of increased intake of fruits and vegetables and whole grains on markers of inflammation and gut microbial composition. The treatment groups are 3 servings of whole grain per day; 5 servings of fruits and vegetables per day; and a control (3 servings of refined grains per day provided).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Oct 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2015

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 4, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 11, 2015

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

May 10, 2019

Completed
Last Updated

June 5, 2019

Status Verified

May 1, 2019

Enrollment Period

1.7 years

First QC Date

November 4, 2015

Results QC Date

November 27, 2017

Last Update Submit

May 22, 2019

Conditions

Keywords

DietWhole grainFruitsVegetablesGut healthAnti-inflammatory

Outcome Measures

Primary Outcomes (4)

  • Change in Interleukin-6 (Value at Week 8 Minus Value at Week 0)

    Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for interleukin-6 concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.

    8 weeks

  • Change in Tumor Necrosis Factor-α (Value at Week 8 Minus Value at Week 0)

    Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for tumor necrosis factor-α concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.

    8 weeks

  • Change in High Sensitivity C-reactive Protein (Value at Week 8 Minus Value at Week 0)

    Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for high sensitivity C-reactive protein concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.

    8 weeks

  • Change in Lipopolysaccharide Binding Protein (Value at Week 8 Minus Value at Week 0)

    Plasma samples collected from participants at the beginning (week 0) and end of the study (week 8) will be analyzed for lipopolysaccharide binding protein concentrations using an enzyme linked immunosorbent assay. Changes in the concentrations of these inflammatory markers will be determined from week 0 to week 8.

    8 weeks

Secondary Outcomes (3)

  • Change in Gut Microbiota Shannon's Alpha Diversity (Value at Week 8 Minus Value at Week 0)

    8 weeks

  • Change in Fecal Short Chain Fatty Acids (Value at Week 8 Minus Value at Week 0)

    8 weeks

  • Change in Branched Chain Fatty Acids (Value at Week 8 Minus Value at Week 0)

    8 weeks

Other Outcomes (1)

  • Change in Body Mass Index (Value at Week 8 Minus Value at Week 0)

    8 weeks

Study Arms (3)

Control

EXPERIMENTAL

3 servings of refined grains per day.

Other: Control

Fruits and Vegetables

EXPERIMENTAL

5 servings of fruits and vegetable per day.

Other: Fruits and Vegetables

Whole Grain

EXPERIMENTAL

3 servings of whole grains per day.

Other: Whole Grain

Interventions

5 servings of fruits or vegetables

Fruits and Vegetables

3 servings of whole grain

Whole Grain
ControlOTHER

3 servings of refined grain

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Obese or overweight men or women (body mass index, BMI, ≥25 kg/m2)
  • Free of known gastrointestinal disease
  • No supplements use (excluding multivitamin)
  • Participate in less than 1 h of exercise per week
  • Have not taken antibiotics in the last six months

You may not qualify if:

  • Men and women with fruits and vegetable intake exceeding 2 servings/day
  • Men and women with whole grain intakes exceeding 1 serving/day
  • Pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Food Innovation Center

Lincoln, Nebraska, 68588, United States

Location

Related Publications (1)

  • Kopf JC, Suhr MJ, Clarke J, Eyun SI, Riethoven JM, Ramer-Tait AE, Rose DJ. Role of whole grains versus fruits and vegetables in reducing subclinical inflammation and promoting gastrointestinal health in individuals affected by overweight and obesity: a randomized controlled trial. Nutr J. 2018 Jul 30;17(1):72. doi: 10.1186/s12937-018-0381-7.

MeSH Terms

Conditions

ObesityOverweight

Interventions

FruitVegetablesWhole Grains

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesEdible GrainCrops, AgriculturalSeeds

Results Point of Contact

Title
Dr. Devin Rose
Organization
University of Nebraska Lincoln

Study Officials

  • Devin J Rose, PhD

    University of Nebraska

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

November 4, 2015

First Posted

November 11, 2015

Study Start

October 1, 2015

Primary Completion

June 1, 2017

Study Completion

July 1, 2017

Last Updated

June 5, 2019

Results First Posted

May 10, 2019

Record last verified: 2019-05

Locations